BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26110817)

  • 1. Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan.
    Azuma T; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Sato T; Yamashita N; Tanaka H; Mino Y
    PLoS One; 2015; 10(6):e0131412. PubMed ID: 26110817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of new three anti-influenza drugs and one prodrug in the water environment.
    Azuma T; Ishida M; Hisamatsu K; Yunoki A; Otomo K; Kunitou M; Shimizu M; Hosomaru K; Mikata S; Mino Y
    Chemosphere; 2017 Feb; 169():550-557. PubMed ID: 27898328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak.
    Azuma T; Nakada N; Yamashita N; Tanaka H
    Environ Sci Technol; 2012 Dec; 46(23):12873-81. PubMed ID: 23106220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
    Ghosh GC; Nakada N; Yamashita N; Tanaka H
    Environ Health Perspect; 2010 Jan; 118(1):103-7. PubMed ID: 20056566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak.
    Azuma T; Nakada N; Yamashita N; Tanaka H
    Chemosphere; 2013 Nov; 93(9):1672-7. PubMed ID: 23871592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction, risk and control of anti-influenza drugs in the Yodo River Basin, Japan during seasonal and pandemic influenza using the transmission model for infectious disease.
    Azuma T; Nakada N; Yamashita N; Tanaka H
    Sci Total Environ; 2015 Jul; 521-522():68-74. PubMed ID: 25828414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants.
    Ghosh GC; Nakada N; Yamashita N; Tanaka H
    Chemosphere; 2010 Sep; 81(1):13-7. PubMed ID: 20692015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin, Japan.
    Azuma T; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Sato T; Mino Y
    Environ Sci Pollut Res Int; 2015 Dec; 22(23):18676-86. PubMed ID: 26178832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the antiviral drug oseltamivir in aquatic environments.
    Söderström H; Järhult JD; Olsen B; Lindberg RH; Tanaka H; Fick J
    PLoS One; 2009 Jun; 4(6):e6064. PubMed ID: 19557131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic.
    Leknes H; Sturtzel IE; Dye C
    Sci Total Environ; 2012 Jan; 414():632-8. PubMed ID: 22127154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H; Kawai N; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
    Straub JO
    Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
    Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
    Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
    Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
    Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antiyellowing agents as precursors of N-nitrosodimethylamine production on ozonation from sewage treatment plant influent.
    Kosaka K; Asami M; Konno Y; Oya M; Kunikane S
    Environ Sci Technol; 2009 Jul; 43(14):5236-41. PubMed ID: 19708347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents.
    Azuma T; Arima N; Tsukada A; Hirami S; Matsuoka R; Moriwake R; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Mino Y; Hayashi T; Fujita Y; Masada M
    Sci Total Environ; 2016 Apr; 548-549():189-197. PubMed ID: 26802347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada.
    Metcalfe CD; Miao XS; Koenig BG; Struger J
    Environ Toxicol Chem; 2003 Dec; 22(12):2881-9. PubMed ID: 14713027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.